Pentraxins and atherosclerosis: the role of PTX3
Options
Publisher DOI
PubMed ID
21226667
Description
Pentraxins are a family of evolutionarily conserved multifunctional pattern-recognition proteins characterized by a cyclic multimeric structure. Based on the primary structure of the subunit, the pentraxins are divided into two groups: short pentraxins and long pentraxins. C-reactive protein (CRP) and serum amyloid P-component (SAP) are the two short pentraxins. The prototype protein of the long pentraxin group is pentraxin 3 (PTX3). CRP and SAP are produced primarily in the liver in response to IL-6, while PTX3 is produced by a variety of tissues and cells and in particular by innate immunity cells in response to proinflammatory signals and Toll-like receptor (TLR) engagement. PTX3 interacts with several ligands, including growth factors, extracellular matrix components and selected pathogens, playing a role in complement activation and facilitating pathogen recognition by phagocytes, acting as a predecessor of antibodies. In addition, PTX3 is essential in female fertility by acting as a nodal point for the assembly of the cumulus oophorus hyaluronan-rich extracellular matrix. Here we will concisely review the general properties of PTX3 in the context of the pentraxin superfamily and discuss recent data suggesting that PTX3 plays a cardiovascular protective effect. PTX3 may represent a new marker in vascular pathology which correlates with the risk of developing vascular events.
Date of Publication
2011
Publication Type
Article
Language(s)
en
Contributor(s)
Garlanda, Cecilia | |
Bottazzi, Barbara | |
Deban, Livija | |
Molla, Fabiola | |
Latini, Roberto | |
Mantovani, Alberto |
Additional Credits
Series
Current pharmaceutical design
Publisher
Bentham Science Publishers
ISSN
1381-6128
Access(Rights)
metadata.only